← Mechanisms of action
C5
SINGLE PROTEINHomo sapiens
Preferred name: Complement C5 ChEMBL ↗
Linked proteins
Drugs acting on this target (24)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| Gefurulimab | Agonist | experimental | mAb | C5 agonist |
| Gefurulimab | Antagonist | experimental | mAb | C5 antagonist |
| ravulizumab-cwvz (ultomiris) | Antagonist | approved | mAb | C5 antagonist |
| adx-038 | Antisense inhibitor | experimental | Nucleic acid | C5 antisense inhibitor |
| syh2061 | Antisense inhibitor | experimental | Nucleic acid | C5 antisense inhibitor |
| zilucoplan (ZILBRYSQ) | Binding agent | approved | Small molecule | Complement C5 binding agent |
| alxn1007 | Inhibitor | experimental | mAb | C5 inhibitor |
| arc1905 | Inhibitor | experimental | Nucleic acid | C5 inhibitor |
| avacincaptad pegol (Izervay) | Inhibitor | approved | Peptide | C5 inhibitor |
| cemdisiran | Inhibitor | experimental | Nucleic acid | C5 inhibitor |
| coversin | Inhibitor | experimental | Peptide | C5 inhibitor |
| crovalimab (PIASKY) | Inhibitor | approved | mAb | Complement C5 inhibitor |
| eculizumab (Soliris) | Inhibitor | approved | mAb | C5 inhibitor |
| ibi302 | Inhibitor | experimental | mAb | C5 inhibitor |
| ifx-1 | Inhibitor | experimental | mAb | C5 inhibitor |
| im-101 | Inhibitor | experimental | mAb | C5 inhibitor |
| lfg316 | Inhibitor | experimental | mAb | C5 inhibitor |
| lp-005 | Inhibitor | experimental | mAb | C5 inhibitor |
| medi7814 | Inhibitor | experimental | mAb | C5 inhibitor |
| pozelimab (Veopoz) | Inhibitor | approved | mAb | Complement C5 inhibitor |
| ravulizumab-cwvz (ultomiris) | Inhibitor | approved | mAb | Complement C5 inhibitor |
| rlyb116 | Inhibitor | experimental | mAb | C5 inhibitor |
| sobi002 | Inhibitor | experimental | Small molecule | C5 inhibitor |
| zilucoplan (ZILBRYSQ) | Inhibitor | approved | Small molecule | C5 inhibitor |